William Porter

William Porter has had a rich and diverse work experience spanning various companies and roles. William started their career in 2006 as an Analyst at Capital IQ, eventually moving up to become a Senior Associate and then an Associate in Business Development. In 2011, they joined S&P Capital IQ as the Director of Business Development and later became the Director of Market Development in the Investment Management department.

In 2012, William transitioned to ZocDoc, where they served as the Director of Strategic Sales. Following their time at ZocDoc, they joined Force Therapeutics in 2013 as the Vice President, heading the Sales, Marketing, and Business Development departments until 2019.

Continuing their career progression, William became a part of Butterfly Network, Inc. in 2019, where they initially took on the role of VP & GM of Enterprise Solutions. William later moved on to become the VP & GM of International prior to joining Bayesian Health as their Chief Commercial Officer in 2023.

Throughout their career, William has also demonstrated their expertise and commitment to the healthcare industry by contributing as an Advisory Board Member for Bayesian Health from 2020 to 2022. William has also been an active member of the New York Revenue Collective since 2018.

William Porter has a Bachelor of Arts degree in Management and Economics from Gettysburg College. Additionally, they have attended the Danish Institute for Study Abroad, where they studied International Business and Economics. However, specific start and end years for both institutions are not provided.